| CMSC | -0.6% | 23.52 | $ | |
| GSK | 2.35% | 58.62 | $ | |
| RIO | -2.83% | 93.83 | $ | |
| BCC | -0.36% | 89.915 | $ | |
| BCE | -3.54% | 25.43 | $ | |
| NGG | -1.4% | 86.61 | $ | |
| JRI | 1.09% | 13.29 | $ | |
| RBGPF | 5.11% | 86.52 | $ | |
| AZN | 1.16% | 189.85 | $ | |
| BTI | 0.1% | 61.705 | $ | |
| RELX | 3.87% | 30.98 | $ | |
| VOD | -6.56% | 14.743 | $ | |
| BP | -2.34% | 38.3 | $ | |
| RYCEF | -1.87% | 16.62 | $ | |
| SCS | 0.12% | 16.14 | $ | |
| CMSD | -0.13% | 23.869 | $ |
Wind turbine maker Vestas sees record revenue in 2025
Denmark's Vestas, Europe’s leading wind turbine manufacturer, on Thursday posted an all-time high revenue, but noted that regulatory changes in the United states had made wind power investments less attractive.
Vestas recorded revenue 18.8 billion euros ($22.2 billion) in 2025, up nine percent compared to the year before.
It also posted a net profit of 778 million euros, a 55 percent increase.
The group also said it had a record order backlog worth 71.9 billion euros at the end of 2025.
That corresponds to orders representing 23 gigawatts for onshore wind, its core business, and eight gigawatts for offshore wind. Service orders represented more than half of the total at 38.7 billion euros.
For 2026, Vestas is forecasting revenue between 20 and 22 billion euros, while noting that "ongoing geopolitical and tariff risks are likely to cause uncertainty".
In the United States, Vestas's largest market, "regulatory changes made future clean energy investments less attractive compared to previously," the company noted, and expressed concern that "tariff uncertainty remains".
A. Nunes--JDB